StockVS

Transcat, Inc. (TRNS) Aandelenanalyse

Industrie

Transcat, Inc.

$76.45

+$3.43 (+4.70%)

Laatst bijgewerkt: 26 mei 2026

Koersverloop

Analyse

Bedrijfsoverzicht

Transcat, Inc. is a provider of calibration and laboratory instrument services that operates across the United States, Canada, and international markets through its Service and Distribution segments. The company functions within the Industrials sector, specifically in the Specialty Business Services industry, which denotes its focus on specialized technical support rather than the production of core industrial goods. This entity employs 1.245 thousand people and holds a market capitalization of $757.96 million, reflecting a mid-to-large cap position within its niche. With annual revenue of $319.69 million, these financial metrics indicate that the business has achieved a significant scale, allowing it to leverage its service footprint to capture demand for essential instrument maintenance and qualification.

Financiële gezondheid

Transcat reported total revenue of $319.69 million for the trailing twelve months, generating net income of $7.89 million and an EBITDA of $41.33 million. The substantial gap between the reported revenue and the net income reveals a cost structure where operating expenses, likely driven by labor and logistics in a service-heavy model, consume a large portion of gross earnings before reaching the bottom line. The company generated free cash flow of $25.09 million, which provides a robust level of financial flexibility to fund operational needs, service contracts, and potential capital expenditures without relying heavily on external financing. Profitability is characterized by a gross margin of 32.5%, an operating margin of 1.0%, and a profit margin of 2.5%, indicating that while the company maintains healthy pricing power on its gross sales, high operating costs compress earnings available to shareholders. The balance sheet shows a cash balance of $3.47 million against total debt of $134.00 million, resulting in a debt-to-equity ratio of 45.15, which suggests a leveraged capital structure where debt obligations significantly outweigh liquid cash reserves. Liquidity management is supported by a current ratio of 2.21, indicating that the company holds more than twice the current assets necessary to cover its short-term liabilities. Return on Equity stands at 2.7% and Return on Assets is 2.4%, metrics that reveal the current effectiveness of management in generating returns relative to the equity invested and the total asset base utilized.

Waarderingsbeoordeling

Valuation metrics show a trailing P/E ratio of 95.55 compared to a forward P/E of 39.33, implying that the market expects a significant increase in earnings to justify the current price level. The price-to-book ratio is 2.55, indicating that the market prices the company at a premium of 155% over its book value, which may reflect confidence in its service intangibles or growth prospects. Alternative valuation multiples include a price-to-sales ratio of 2.37 and an EV/EBITDA of 21.50, suggesting that while the stock trades at a high multiple relative to sales, the enterprise value relative to earnings is somewhat more grounded compared to the P/E compression. The stock has a 52-week high of $97.08 and a 52-week low of $50.23, meaning the current trading price sits significantly below the yearly peak but above the yearly trough. The beta of 0.70 indicates that the stock exhibits lower volatility than the broader market, moving with less intensity than the general equity index during periods of market fluctuation.

Growth & Income

Revenue growth for the trailing twelve months stands at 25.6%, while earnings growth data is listed as N/A for the period provided. The absence of reported earnings growth alongside strong revenue expansion suggests that cost growth may be keeping pace with top-line gains, preventing earnings from accelerating at a faster rate than sales. The company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which implies that earnings are reinvested back into the business for expansion or operational improvements rather than being distributed to shareholders. Consequently, the overall growth and income profile is defined by capital appreciation potential driven by revenue expansion rather than income generation through dividend payments, creating a return profile reliant on share price appreciation and operational efficiency improvements.

Vergelijking met sectorgenoten

Transcat, Inc. (TRNS) is actief in de Gespecialiseerde Zakelijke Diensten-sector. Zo verhoudt het zich tot de naaste sectorgenoten op basis van marktkapitalisatie:

Bedrijf Ticker Marktkapitalisatie K/W-verhouding
Transcat, Inc. TRNS $713.45M 134.1
Cintas Corporation CTAS $68.46B 36.1
RELX PLC RELX $58.35B 21.9
Thomson Reuters Corporation TRI.TO $50.46B 24.1

De gemiddelde K/W-verhouding in de Gespecialiseerde Zakelijke Diensten-sector is 65.9x. Transcat, Inc. wordt verhandeld tegen een K/W van 134.1.

Deze analyse is gegenereerd door AI en dient alleen ter informatie. Het vormt geen financieel advies. Gegevens kunnen vertraagd of onnauwkeurig zijn. Doe altijd je eigen onderzoek en raadpleeg een gekwalificeerde financieel adviseur voordat je beleggingsbeslissingen neemt.

Over Transcat, Inc.

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control, and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value-added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense, industrial manufacturing, energy and utilities, chemical manufacturing, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.

Bedrijfsbeschrijving wordt in het Engels weergegeven.

Bezoek website →

Belangrijke Cijfers

Marktkapitalisatie
$713.45M
K/W-verhouding
134.12
52-weken hoog
$93.20
52-weken laag
$50.23
Gem. Volume
134.59K

Gegevens verstrekt door Yahoo Finance via yfinance. Dagelijks bijgewerkt.

Bedrijfsinfo

Beurs
NASDAQ
Land
United States